After Pfizer, US clears second Covid pill
"Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," said FDA scientist Patrizia Cavazzoni.
Washington
The US Food and Drug Administration (FDA) on Thursday authorized Merck's Covid pill for high risk adults, a day after a similar pill by Pfizer was given the green light.
"Today's authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally," said FDA scientist Patrizia Cavazzoni.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android